期刊： AMERICAN HEART JOURNAL, 2022; 251 ()
Background For ST-segment elevation myocardial infarction (STEMI) patients presenting 24 to 48 hours from symptom onset, whether early invasive strate......
期刊： AMERICAN HEART JOURNAL, 2022; 248 ()
Background Long-term patterns of the triglyceride-glucose index (TyG index) and their effects on cardiovascular dis-ease (CVD) among normal-weight adu......
期刊： AMERICAN HEART JOURNAL, 2022; 244 ()
Background The efficacy and safety of intravenous infusion of nicorandil during primary percutaneous coronary intervention (PCI) in patients with ST-e......
期刊： AMERICAN HEART JOURNAL, 2022; 248 ()
First approved in July 2015, proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors are costly lipid-lowering drugs. Their utilization has i......
期刊： AMERICAN HEART JOURNAL, 2022; 243 ()
Background The EROSION study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography-Based Management in Plaqu......
期刊： AMERICAN HEART JOURNAL, 2022; 254 ()
Background Although patients with CLTI have benefited from the rapid development of endovascular techniques, many patients are considered unsuitable f......
期刊： AMERICAN HEART JOURNAL, 2022; 244 ()
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease characterized by fibrofatty replacement of the ......
期刊： AMERICAN HEART JOURNAL, 2021; 237 ()
Background Studies found that patients who underwent coronary artery bypass grafting (CABG) often fail to receive optimal evidence-based secondary pre......
期刊： AMERICAN HEART JOURNAL, 2021; 238 ()
Background Diabetes has become a major public health challenge worldwide, especially in low- and middle-income countries (LMICs). Uncontrolled hypergl......
期刊： AMERICAN HEART JOURNAL, 2021; 236 ()
Background Current guidelines recommend administering dual antiplatelet therapy (DAPT) for 12 months to patients with acute coronary syndromes (ACS) a......
期刊： AMERICAN HEART JOURNAL, 2021; 233 ()
We aimed to assess the efficacy and safety of canagliflozin in patients with type 2 diabetes and nephropathy according to prior history of heart failu......
期刊： AMERICAN HEART JOURNAL, 2021; 234 ()
Background Double kissing (DK) crush approach for patients with coronary bifurcation lesions, particularly localized at distal left main or lesions wi......
期刊： AMERICAN HEART JOURNAL, 2021; 234 ()
Background Previous studies have proposed growth differentiation factor-15 (GDF-15) as a predictor of adverse cardiovascular outcomes and mortality. T......
期刊： AMERICAN HEART JOURNAL, 2021; 231 ()
Background Dual antiplatelet therapy (DAPT) is key for the prevention of recurrent ischemic events after percutaneous coronary intervention (PCI); how......
